| Current dividend yield | 6.35 % |
| Dividendenrendite 5 Jahre | 9.15 % |
| Dividend Yield 10Y | 5.67 % |
| Payout 3Y | 8.43 % |
The Simcere Pharmaceutical Group stock dividend is paid once a year. In order to receive a dividend, you should generally own the Simcere Pharmaceutical Group stock before the ex-dividend date. The Dividend Calendar shows that the ex-day date was last at June . The dividend from Simcere Pharmaceutical Group was paid in July.
| Year | Dividend | Ex-day & Payday |
Frequency | |
|---|---|---|---|---|
| Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
| 2026 |
HK$0.2069
HK$0.21
|
Jun 17 2026
Jun 17 2026
Jul 13 2026
Jun 17 26
Jul 13 26 |
Jul 13 2026 |
annual
yearly
|
| 2025 |
HK$0.1748
HK$0.17
|
Jun 18 2025
Jun 18 2025
Jul 14 2025
Jun 18 25
Jul 14 25 |
Jul 14 2025 |
annual
yearly
|
| 2024 |
HK$0.1757
HK$0.18
|
Jun 18 2024
Jun 18 2024
Jul 15 2024
Jun 18 24
Jul 15 24 |
Jul 15 2024 |
annual
yearly
|
| 2023 |
HK$0.17576
HK$0.18
|
Jun 19 2023
Jun 19 2023
Jul 12 2023
Jun 19 23
Jul 12 23 |
Jul 12 2023 |
annual
yearly
|
| 2022 |
HK$0.1757
HK$0.18
|
Jun 28 2022
Jun 28 2022
Jul 15 2022
Jun 28 22
Jul 15 22 |
Jul 15 2022 |
annual
yearly
|
| 2021 |
HK$0.18031
HK$0.18
|
Jun 29 2021
Jun 29 2021
Jul 16 2021
Jun 29 21
Jul 16 21 |
Jul 16 2021 |
annual
yearly
|
Simcere Pharmaceutical Group paid a Dividend of HK$0.21 Per Share in the financial year 2026. With a stock price of HK$11.17 at Sep 18 2026, the current dividend yield is 1.85% (calculation: HK$0.21 / HK$11.17 = 1.85%). No special dividend was paid.
The average Simcere Pharmaceutical Group dividend yield over the last 5 years is 2.03% and the average over the last 10 years is 1.22%.
The payout ratio of Simcere Pharmaceutical Group in relation to the last financial year is 27.75%. The payout ratio smoothed over 3 years is 40.80%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
| Metric | Simcere Pharmaceutical Group |
|---|---|
| Current dividend yield | 1.85% |
| Dividend Yield 5Y | 2.03% |
| Dividend Yield 10Y | 1.22% |
| Payout 1Y | 27.75% |
| Payout 3Y | 40.80% |
Simcere Pharmaceutical Group has been paying a dividend for 6 years and has not reduced the dividend since 1 (dividend continuity). As a result, the dividend was recently increased 1-times.
The Dividend Growth in relation to the previous financial year amounts to 18.36%. The average Simcere Pharmaceutical Group Dividend Growth over the last 5 years is 2.79%.
| Metric | Simcere Pharmaceutical Group |
|---|---|
| Increased | 1 Year |
| Continuity | 1 Year |
| Paid | 6 Years |
| Growth 1Y | 18.36% |
| Growth 5Y | 2.79% |
Simcere Pharmaceutical Group has been paying a dividend for 6 years and has not reduced the dividend since 1 (dividend continuity). As a result, the dividend was recently increased 1-times.
The Dividend Growth in relation to the previous financial year amounts to 18.36%. The average Simcere Pharmaceutical Group Dividend Growth over the last 5 years is 2.79%.
On the stock exchange, the Simcere Pharmaceutical Group stock (ISIN: HK0000658531) is not traded as a top scorer in September 2026 according to the dividend strategy.
The stock price of Simcere Pharmaceutical Group -3.01% has fallen since the beginning of the year 2026. However, the return generated in the past says nothing about the future return. You can find the Simcere Pharmaceutical Group stock price in real time at the top of the page.
Simcere Pharmaceutical Group (symbol: 2096) is valued at a Price / Earnings Ratio (P/E ratio) of 15.73 and a price/sales ratio (P/S ratio) of 2.83 valued. Based on analyst estimates, the Simcere Pharmaceutical Group stock forecast 2026 of the current financial year corresponds to a valuation of 14.21 according to P/E ratio and 2.43 according to P/S.
| Metric | Simcere Pharmaceutical Group |
|---|---|
| Dividend Score | ??/15 |
| Performance 2026 |
3.01%
|
| P/E TTM | 15.73 |
| P/S TTM | 2.83 |
| P/E forward | 14.21 |
| P/S forward | 2.43 |
Simcere Pharmaceutical Group (symbol: 2096) is valued at a Price / Earnings Ratio (P/E ratio) of 15.73 and a price/sales ratio (P/S ratio) of 2.83 valued. Based on analyst estimates, the Simcere Pharmaceutical Group stock forecast 2026 of the current financial year corresponds to a valuation of 14.21 according to P/E ratio and 2.43 according to P/S.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


